🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

After moments of entering one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, messages display black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious medical dangers”.